[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
date : 10/24/2024
Tags: AMR, HGPI Salon, HGPI Seminar
Health and Global Policy Institute (HGPI) has organized HGPI Salon for individual supporting members and those interested in health care policy from various fields.
On October 21, 2024, the lecture for the special edition was given by Mr. Yann Ferrisse, Director of Business Development & Partner Engagement, GARDP (Global Antibiotic Research & Development Partnership).
GARDP is a not-for-profit global health organization driven to protect people from the rise and spread of drug-resistant infections, one of the biggest global health threats. It was set up by the World Health Organization and DNDi in 2016. Since 2019, the Government of Japan has provided GARDP with financial support as a contribution to global health initiatives.
Through its cost-effective partnership model, GARDP develops appropriate antibiotic treatments to be made available to the people who need them, in particular those in low- and middle-income countries. The heart of GARDP’s work are partnerships that go beyond the conventional boundaries of industry, government, and academia.
At this HGPI Salon, Mr. Yann introduced various initiatives, including examples of collaborations with companies, efforts to promote technology transfer of antimicrobial agents, challenges in multi-stakeholder cooperation, and types of partnerships necessary for healthcare policies, including infectious disease control. After that, Dr. Seamus O’Brien, R&D Director, GARDP, joined the Q&A session to discuss the paths and difficulties in building effective global partnerships based on everyone’s extensive experience in establishing numerous global collaborations. This event was a great chance to provide an opportunity to deepen understanding of how partnerships should be built in Japan and around the world in the future.

* For individual supporting members only, links to this HGPI Salon’s materials and video recordings will be shared at a later date.
■ Supporting member of HGPI (Annual membership fee 10,000 yen)
HGPI conducts its work with financial support from foundations and companies as well as individual members, both domestic and international. Your continued support enables HGPI to continue its activities as a non-profit, non-partisan think tank. We greatly appreciate your generous support.
To register as a supporting member, please check this link.
■Profile
Mr. Yann Ferrisse (Director of Business Development & Partner Engagement, GARDP)
Yann Ferrisse joined GARDP in January 2018, initially as a Business Development and Analysis Leader. Since October 2022, he has held the position of Business Development & Partner Engagement Director. In this role, he manages all interactions with private partners to enrich GARDP’s portfolio and ensure product delivery at the national/regional level.Prior to joining GARDP, Yann was Managing Director of an innovation consulting firm, focused on exploring and developing uncharted territory. He was responsible for setting up country offices in Europe and Asia.
Alongside his principal role in business development, Yann has been instrumental in the creation of SECURE, an initiative to expand access to essential antibiotics, in close collaboration with WHO and with strategic input from CHAI and UNICEF.Between 2010 and 2015, Yann was invited to join the Conseillers du Commerce Extérieur de la France, where he acted as French Foreign Trade Advisor.
[Overview]
- Speaker: Mr. Yann Ferrisse (Director, Business Development & Partner Engagement, GARDP)
- Date & Time: Monday, 21 October 2024, 18:00-19:15 (doors open at 17:40) JST
- Format: In-person (lecture materials and recordings will be distributed later to supporting members ONLY.)
- Venue: Global Business Hub Tokyo, Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo
- Language: English and Japanese (with simultaneous interpretation)
- Participation Fee: Free(Regular HGPI Salons are offered as paid sessions)
- Capacity: 50
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #8: Fostering AMR-Conscious Youth: The Antibiotic Smart Sweden Certificate Program and its Implications for Early Childhood Education (July 1, 2026)
- [Research Report] Medical Practitioner Interviews on the Current State and Issues for Interdepartmental Collaboration in Clinical Practice for Chronic Kidney Disease (June 30, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-24
[Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
-
2026-07-30
[Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)



